ORIGINAL RESEARCH article
Front. Oncol., 30 April 2020
Sec. Cancer Genetics
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.00441
RETRACTED: Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1
- XP
Xiaoping Pan 1*
- XH
Xiaolv Hong 2
- JL
Jinguo Lai 1
- LC
Lu Cheng 1
- YC
Yandong Cheng 3
- MY
Mingmei Yao 1
- RW
Rong Wang 1
- NH
Na Hu 1
1. Clinical Laboratory, Huadu Hospital, Southern Medical University, Guangzhou, China
2. Department of Infectious Diseases, Huadu Hospital, Southern Medical University, Guangzhou, China
3. Department of Breast Surgery, Huadu Hospital, Southern Medical University, Guangzhou, China
Summary
Citation
Pan X, Hong X, Lai J, Cheng L, Cheng Y, Yao M, Wang R and Hu N (2020) RETRACTED: Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1. Front. Oncol. 10:441. doi: 10.3389/fonc.2020.00441
Received
12 December 2019
Accepted
12 March 2020
Published
30 April 2020
Volume
10 - 2020
Edited by
Xiao Zhu, Guangdong Medical University, China
Reviewed by
Fengchao Lang, University of Pennsylvania, United States; Chen Li, Charité—Universitätsmedizin Berlin, Germany
Updates
This article was submitted to Cancer Genetics, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.